GMP Peptides

Neoantigen Peptide Manufacturing

Prompt delivery of neoantigen GMP peptides for immunotherapy applications including
peptide vaccine API drug substances up to phase I clinical trials, ex vivo cell therapy, or for EIND (emergency IND) use. Expeditious turn-around times to meet tight scheduling requirements of multiple, individually manufactured and QC tested peptides.

*Not for individual use; available to approved organizations only.

Request a quote

Privileged Partner for project-based management

We can execute individual peptide manufacturing batches for multiple projects concurrently. Production slot reservations can be organized to optimize delivery schedules.

Key advantages of our Neoantigen Service

We are your CMO for custom Neoantigen manufacturing and consistently strive to exceed expectations in quality and service. For nearly 30 years, our customers have leveraged our vast expertise in peptide synthesis and combinatorial chemistry to help achieve their goals.

Timely turn-around

We have the expertise and the technical know-how to manufacture the highest quality of Neoantigen peptides promply.

Technical Expertise

We are pioneers in peptide technology & combinatorial chemistry innovations.

Project Management

We guarantee that you will be kept updated throughout the entire production process.

Traceability

All materials and processes are traceable using batch production records and robust standard operating procedures.

IND Support

IND filling support with complete Chemistry, Manufacturing and Control (CMC) package.

Quality

All Neoantigen peptides are manufactured in our certified ISO 7 classified cleanrooms (10,000) using our stringent QMS.

Neoantigen specifications

We manufacture neoantigen peptides for your personalized immunotherapy studies according to your unique requirements. We implement robust analytical methods for QC testing and characterization of your GMP Starting Material peptide products.

Length: <42 amino acids (typical 16-35 aa)
Number: Multiple Individual peptides
Purity: 90%, 95%, 98%
Counter-ion: Trifluoro acetic acid (TFA), Acetate, or Chloride
Validated analytic testing methods
Robust QC testing attributes

Your project from start to finish

We will guide you from the initial discussions on CDA and MSA agreements,
to manufacturing, testing and product release.

Customer Discussions

CDA & supplier contracts, product specifications, customer audits

Feasibility study¹

Small scale production using released raw materials for feasibility.

¹when applicable

Setup

Identification & setting of critical manufacturing parameters.

GMP Manufacturing

Cleanroom manufacturing of the peptides under our QMS using Batch Production Records & SOP’s.

QC Testing & Release

QC release of the product followed by QA review of the manufacturing/testing records, shipping.

Neoantigen vaccines for immunotherapy

Cancer sporadically originates from normal tissues through the accumulation of genetic and epigenetic aberrations.

This genetic instability of cancer cells often leads to the production of abnormal tumor proteins not found in normal cells, called Tumor-Specific Neoantigens (TSNAs), which pose promising opportunities for the development of new vaccines.

Therapeutic cancer vaccines act by inducing tumor degradation, eliminating minimal residual disease, and creating continuous anticancer memory.

Contact us to discuss your Neoantigen project

Start now

Custom Peptides Synthesis

Assay Kits

Bulk Quantities

Custom Request

Bulk Quantities

Neoantigen GMP peptides

Request a Quote

Request a Quote